CoreRx, Aimmune Unveil Joint Expansion

CoreRx, a contract development and manufacturing organization (CDMO), and Aimmune Therapeutics, a clinical-stage biopharmaceutical company advancing a therapeutic approach for the treatment of peanut and other food allergies, together, have increased manufacturing operations at CoreRx's ICOT Center campus in Clearwater, FL.

This new expansion consists of approximately 20,000 square feet of manufacturing and warehouse space at CoreRx's 5733 Myerlake Circle (ML-3) location. This growth will necessitate additional staffing at CoreRx including positions within pharmaceutical development, manufacturing, engineering, quality assurance and packaging.

"The Tampa Bay area is a great place to expand the base of scientific capabilities," said said Todd Daviau, president and chief executive officer, CoreRx. "These expansions in the private-sector result in high-paying, skilled roles that contribute immensely to society by providing products and services that impact the quality of lives of Americans. These expansions continue to showcase the Tampa regions expertise in high technology manufacturing on a national and global level. And, we will continue to expand our capabilities to meet the growing demands of our clients."